Skip to main content

Published locations for FDA approves ibrutinib-rituximab combo for newly diagnosed CLL, SLL in adults

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves ibrutinib-rituximab combo for newly diagnosed CLL, SLL in adults

User login

  • Reset your password
  • /content/fda-approves-ibrutinib-rituximab-combo-newly-diagnosed-cll-sll-adults
  • /hematologynews/article/221171/cll/fda-approves-ibrutinib-rituximab-combo-newly-diagnosed-cll-sll
  • /oncologypractice/article/221171/cll/fda-approves-ibrutinib-rituximab-combo-newly-diagnosed-cll-sll
  • /jcomjournal/article/221171/cll/fda-approves-ibrutinib-rituximab-combo-newly-diagnosed-cll-sll-adults
  • /hematology-oncology/article/221171/cll/fda-approves-ibrutinib-rituximab-combo-newly-diagnosed-cll
  • /b-cell-lymphoma-icymi/article/221171/cll/fda-approves-ibrutinib-rituximab-combo-newly-diagnosed-cll